Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
fda
life sciences
national blog main
san francisco blog main
2
×
akouos
arena pharmaceuticals
astellas pharmaceuticals
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer
cardiovascular disease
colorectal cancer
deals
decibel therapeutics
detroit blog main
detroit top stories
eisai
europe blog main
europe top stories
frequency therapeutics
harvard university
hearing loss
indiana blog main
indiana top stories
investing
jeffrey karp
lorcaserin
lung cancer
multiple sclerosis
national
national top stories
new york blog main
new york top stories
obsesity
What
drug
fda
2
×
loss
2
×
affects
americans
approved
cancer
date
developing
eisai
flags
frequency
hearing
higher
incidence
ipo
lorcaserin
market
marketing
medicine
medicines
meds
millions
patients
plans
post
pulls
regenerative
risks
study
therapeutics
took
treat
weight
withdrawing
Language
unset
Current search:
loss
×
fda
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
